Publications

Strategy does not guarantee business success. But the absence of strategy almost certainly guarantees failure.

In our industry, we often talk about translation quality as the key success factor for any project. But I can say with certainty that the final result doesn’t begin when the translator opens a file – it starts much earlier, at the stage of technical file preparation for translation.

2025 was the first year when the language services industry truly felt the cold breath of AI. This impact was further intensified by today’s geopolitical reality, especially the slowdown in global trade caused by tariffs and sanctions.

The Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) have transformed localization into a discipline focused on change management. It’s no longer a matter of “Translate once and then forget.” Instead, it demands ongoing lifecycle management.

In early 2024, the Janus Worldwide team launched a large-scale initiative to implement its proprietary AI plugin in real-world production scenarios. The approach was practical and business-oriented: how to reduce translation costs without sacrificing quality, especially in the face of limited budgets and strict client deadlines.

Artificial intelligence has become firmly established in everyday localization processes. However, it is important to understand: not all AI translations are created equal. With increasing demands on quality, deadlines, and stylistic accuracy, machine translation alone is not enough for clients. They need it a real intellectual tool, adapted to their content, style and objectives.

Machine translation, even built on the most modern LLM models, must not only sound smart, but also be objectively qualitative. At Janus Worldwide, we are confident that artificial intelligence is not magic, but a tool whose results can be measure, compare and improve.

In the fast-paced world of medical device manufacturing, safety is always a top priority. However, safety doesn’t just come from high-quality engineering or innovative design. It also hinges on clear communication, especially when it comes to labeling, instructions for use (IFUs), and safety documentation. With the implementation of the EU Medical Device Regulation (MDR 2017/745) and In-vitro Diagnostic Regulation (IVDR 2017/746), these materials are now subject to more stringent localization requirements than ever before.

As 2025 unfolds, the field of multimedia localization is rapidly evolving, shaped by advancements in AI, machine learning, and cloud-based platforms. At Janus Worldwide, we are committed to staying at the forefront of these innovations to deliver cutting-edge localization solutions that ensure global reach and cultural relevance for our clients.

In today’s globalized world, companies are expanding beyond their domestic markets at an unprecedented rate. With this growth comes the need to communicate effectively with diverse audiences, and that’s where localization of marketing materials becomes crucial. At Janus Worldwide, we are committed to helping brands adapt their message to resonate across languages and cultures, ensuring that each communication is not just a translation, but a strategic, culturally-aligned tool for success.